tiprankstipranks
Trending News
More News >
Sana Biotechnology (SANA)
NASDAQ:SANA
US Market

Sana Biotechnology (SANA) Financial Statements

Compare
542 Followers

Sana Biotechnology Financial Overview

Sana Biotechnology's market cap is currently $389.29M. The company's EPS TTM is $-1.171; its P/E ratio is ―; Sana Biotechnology is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -30.86M$ -27.73M$ -17.91M$ -10.17M
Operating Income$ -272.72M$ -326.90M$ -272.56M$ -356.91M$ -286.15M
EBITDA$ -272.72M$ -252.39M$ -256.94M$ -356.91M$ -287.03M
Net Income$ -266.76M$ -283.25M$ -266.39M$ -344.18M$ -278.64M
Balance Sheet
Cash & Short-Term Investments$ 152.50M$ 205.19M$ 434.01M$ 746.88M$ 412.00M
Total Assets$ 501.02M$ 565.30M$ 822.72M$ 1.13B$ 730.30M
Total Debt$ 94.20M$ 104.10M$ 108.25M$ 110.94M$ 71.91M
Net Debt$ -33.37M$ -29.42M$ -68.51M$ -142.09M$ -340.09M
Total Liabilities$ 250.52M$ 277.79M$ 323.40M$ 400.90M$ 1.15B
Stockholders' Equity$ 250.50M$ 287.51M$ 499.31M$ 728.50M$ -421.18M
Cash Flow
Free Cash Flow$ -256.58M$ -273.61M$ -310.93M$ -280.92M$ -161.85M
Operating Cash Flow$ -223.15M$ -253.58M$ -290.05M$ -251.05M$ -137.98M
Investing Cash Flow$ 17.45M$ 172.01M$ 210.56M$ -245.80M$ -252.56M
Financing Cash Flow$ 199.75M$ 31.65M$ 4.91M$ 631.75M$ 435.69M
Currency in USD

Sana Biotechnology Earnings and Revenue History

Sana Biotechnology Debt to Assets

Sana Biotechnology Cash Flow

Sana Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis